These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19063987)

  • 21. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
    Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C;
    PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1.
    Zhang Y; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Murakoshi H; Takiguchi M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.
    Balamurugan A; Ali A; Boucau J; Le Gall S; Ng HL; Yang OO
    J Virol; 2013 Aug; 87(15):8726-34. PubMed ID: 23740989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
    Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P
    Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication.
    Murakoshi H; Kuse N; Akahoshi T; Zhang Y; Chikata T; Borghan MA; Gatanaga H; Oka S; Sakai K; Takiguchi M
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.
    Yager N; Robinson N; Brown H; Flanagan P; Frater J; Fidler S; Weber J; Phillips R;
    AIDS; 2013 Jan; 27(3):313-23. PubMed ID: 23095315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance.
    Cao J; McNevin J; McSweyn M; Liu Y; Mullins JI; McElrath MJ
    J Virol; 2008 Jan; 82(1):495-502. PubMed ID: 17942528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential immune escape mutations under inferred selection pressure in HIV-1 strains circulating in Medellín, Colombia.
    Arcia D; Ochoa R; Hernández JC; Álvarez CM; Díaz FJ; Velilla PA; Acevedo-Sáenz L
    Infect Genet Evol; 2019 Apr; 69():267-278. PubMed ID: 30808498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
    Deng K; Pertea M; Rongvaux A; Wang L; Durand CM; Ghiaur G; Lai J; McHugh HL; Hao H; Zhang H; Margolick JB; Gurer C; Murphy AJ; Valenzuela DM; Yancopoulos GD; Deeks SG; Strowig T; Kumar P; Siliciano JD; Salzberg SL; Flavell RA; Shan L; Siliciano RF
    Nature; 2015 Jan; 517(7534):381-5. PubMed ID: 25561180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.
    Chen DY; Balamurugan A; Ng HL; Cumberland WG; Yang OO
    Blood; 2012 Jul; 120(1):100-11. PubMed ID: 22613796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
    Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
    Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.
    Akahoshi T; Gatanaga H; Kuse N; Chikata T; Koyanagi M; Ishizuka N; Brumme CJ; Murakoshi H; Brumme ZL; Oka S; Takiguchi M
    PLoS Pathog; 2020 Dec; 16(12):e1009177. PubMed ID: 33370400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein.
    Prado JG; Honeyborne I; Brierley I; Puertas MC; Martinez-Picado J; Goulder PJ
    J Virol; 2009 Jan; 83(2):1018-25. PubMed ID: 18945768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates.
    Verheyen J; Schweitzer F; Harrer EG; Knops E; Mueller SM; Däumer M; Eismann K; Bergmann S; Spriewald BM; Kaiser R; Harrer T
    Antivir Ther; 2010; 15(6):907-12. PubMed ID: 20834103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.
    Chopera DR; Ntale R; Ndabambi N; Garrett N; Gray CM; Matten D; Abdool Karim Q; Abdool Karim S; Williamson C
    AIDS; 2017 Jan; 31(2):191-197. PubMed ID: 27755110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.